Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -422,773 | -145,224 | -325,991 | -290,581 | 71,136 |
| Depreciation Amortization | -27,322 | -27,226 | 8,746 | 17,341 | 8,586 |
| Accounts payable and accrued liabilities | 1,437 | 2,431 | 2,274 | 3,705 | -1,623 |
| Other Working Capital | 16,937 | -289,926 | -24,030 | -20,412 | 288,401 |
| Other Operating Activity | 84,027 | 101,954 | 94,285 | 78,558 | 49,652 |
| Operating Cash Flow | $-347,694 | $-357,991 | $-244,716 | $-211,389 | $416,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,912 | -12,939 | -17,833 | -8,500 | -3,095 |
| Purchase Of Investment | -1,229,964 | -1,813,700 | -1,115,040 | -1,422,938 | -1,285,468 |
| Sale Of Investment | 1,157,120 | 2,075,947 | 991,486 | 1,409,812 | 665,357 |
| Investing Cash Flow | $-88,756 | $249,308 | $-141,387 | $-21,626 | $-623,206 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -32,338 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 516,642 | 17,820 | 14,455 | 19,348 | 440,801 |
| Other Financing Activity | 0 | 0 | 296,215 | 0 | 193,948 |
| Financing Cash Flow | $484,304 | $17,820 | $310,670 | $19,348 | $634,749 |
| Beginning Cash Position | 128,681 | 219,544 | 294,977 | 508,644 | 80,949 |
| End Cash Position | 176,535 | 128,681 | 219,544 | 294,977 | 508,644 |
| Net Cash Flow | $47,854 | $-90,863 | $-75,433 | $-213,667 | $427,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -347,694 | -357,991 | -244,716 | -211,389 | 416,152 |
| Capital Expenditure | -15,912 | -12,939 | -17,833 | -8,500 | -3,095 |
| Free Cash Flow | -363,606 | -370,930 | -262,549 | -219,889 | 413,057 |